Ignite Creation Date:
2024-05-06 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05870670
Status:
COMPLETED
Last Update Posted:
2024-05-29
First Post:
2023-05-12
Brief Title:
A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
Investigation of Pharmacokinetics Safety and Tolerability of Multiple Subcutaneous Doses of NNC0519-0130 in Japanese and Non-Japanese Male Participants
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
NNC0519-0130 is a new medicine which may possibly help participants with type 2 diabetes This study will look into how safe the new medicine NNC0519-0130 is and we will measure its concentrations in the blood and look at its effects This study will last for a maximum of 22 weeks and Japanese and Non-Japanese male participants will be included
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1283-0710 | OTHER | World Health Organization WHO | None |